Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SNIFF: Mupirocin for Radiation Mucositis in Head and Neck Cancer
NCT07524894Phase 2Not yet recruiting
- Start
- Jun 2026
- Primary completion
- Jan 2028
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mupirocin in Radiation mucositis (RIM). Planned start Jun 2026; status: not yet recruiting.
02
Drugs
mupirocin
03
Conditions
Radiation mucositis (RIM)
Beyond the preview
Go deeper on NCT07524894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07524894.